Hu, Lirong – Trademark Portfolio

Entity Type: 01

Hu, Lirong owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as HARBYEL, RONTIPATE, and SECODROUT. Of these, 5 are registered. The portfolio spans 3 Nice Classification classes, led by Class 25 (Clothing) and Class 18 (Leather Goods). Headquartered in Wuhan.

Gonggonghu,Maodiansuo Shequ,No. 15-1

Wuhan 430074 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SECODROUT
SECODROUT
Registered 2023
HARBYEL
HARBYEL
Registered 2023
HARBYEL
HARBYEL
Registered 2021
RONTIPATE
RONTIPATE
Registered 2021
SECODROUT
SECODROUT
Registered 2021

Trademark Classifications

Hu, Lirong's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

18
Leather Goods (2 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

Frequently Asked Questions

How many trademarks does Hu, Lirong have?

Hu, Lirong has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Hu, Lirong file in?

Hu, Lirong files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods), Class 6 (Metal Goods). Class 25 covers clothing, footwear, headgear.

What are Hu, Lirong's most well-known trademarks?

Hu, Lirong's registered trademark portfolio includes well-known marks such as HARBYEL, RONTIPATE, and SECODROUT. These are among 5 currently registered trademarks in the portfolio.

What is Hu, Lirong's trademark registration success rate?

Hu, Lirong has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.